Literature DB >> 20708684

Excitotoxicity through Ca2+-permeable AMPA receptors requires Ca2+-dependent JNK activation.

M Vieira1, J Fernandes, A Burgeiro, G M Thomas, R L Huganir, C B Duarte, A L Carvalho, A E Santos.   

Abstract

The GluA4-containing Ca(2+)-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors (Ca-AMPARs) were previously shown to mediate excitotoxicity through mechanisms involving the activator protein-1 (AP-1), a c-Jun N-terminal kinase (JNK) substrate. To further investigate JNK involvement in excitotoxic pathways coupled to Ca-AMPARs we used HEK293 cells expressing GluA4-containing Ca-AMPARs (HEK-GluA4). Cell death induced by overstimulation of Ca-AMPARs was mediated, at least in part, by JNK. Importantly, JNK activation downstream of these receptors was dependent on the extracellular Ca(2+) concentration. In our quest for a molecular link between Ca-AMPARs and the JNK pathway we found that the JNK interacting protein-1 (JIP-1) interacts with the GluA4 subunit of AMPARs through the N-terminal domain. In vivo, the excitotoxin kainate promoted the association between GluA4 and JIP-1 in the rat hippocampus. Taken together, our results show that the JNK pathway is activated by Ca-AMPARs upon excitotoxic stimulation and suggest that JIP-1 may contribute to the propagation of the excitotoxic signal.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708684      PMCID: PMC3003258          DOI: 10.1016/j.nbd.2010.08.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  69 in total

1.  The lethal expression of the GluR2flip/GluR4flip AMPA receptor in HEK293 cells.

Authors:  M Iizuka; S Nishimura; M Wakamori; I Akiba; K Imoto; E L Barsoumian
Journal:  Eur J Neurosci       Date:  2000-11       Impact factor: 3.386

2.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene.

Authors:  D D Yang; C Y Kuan; A J Whitmarsh; M Rincón; T S Zheng; R J Davis; P Rakic; R A Flavell
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

3.  Kainic acid dose affects delayed cell death mechanism after status epilepticus.

Authors:  Daisuke Tokuhara; Satoru Sakuma; Hideji Hattori; Osamu Matsuoka; Tsunekazu Yamano
Journal:  Brain Dev       Date:  2006-06-21       Impact factor: 1.961

4.  The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways.

Authors:  Qiu-Hua Guan; Dong-Sheng Pei; Quan-Guang Zhang; Zhi-Bin Hao; Tian-Le Xu; Guang-Yi Zhang
Journal:  Brain Res       Date:  2005-02-21       Impact factor: 3.252

5.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

6.  Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B.

Authors:  D Feldmeyer; K Kask; R Brusa; H C Kornau; R Kolhekar; A Rozov; N Burnashev; V Jensen; O Hvalby; R Sprengel; P H Seeburg
Journal:  Nat Neurosci       Date:  1999-01       Impact factor: 24.884

7.  Requirement of the JIP1 scaffold protein for stress-induced JNK activation.

Authors:  A J Whitmarsh; C Y Kuan; N J Kennedy; N Kelkar; T F Haydar; J P Mordes; M Appel; A A Rossini; S N Jones; R A Flavell; P Rakic; R J Davis
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

8.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

Review 9.  Molecular mechanisms of calcium-dependent excitotoxicity.

Authors:  R Sattler; M Tymianski
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

10.  D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.

Authors:  E Esneault; V Castagne; P Moser; C Bonny; M Bernaudin
Journal:  Neuroscience       Date:  2008-01-04       Impact factor: 3.590

View more
  7 in total

Review 1.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  Parasynaptic NMDA receptor signaling couples neuronal glutamate transporter function to AMPA receptor synaptic distribution and stability.

Authors:  Larissa A Jarzylo; Heng-Ye Man
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

3.  P38 MAPK inhibition protects against glutamate neurotoxicity and modifies NMDA and AMPA receptor subunit expression.

Authors:  Martha Catalina Rivera-Cervantes; Rolando Castañeda-Arellano; Ruben Darío Castro-Torres; Graciela Gudiño-Cabrera; Alfredo I Feria y Velasco; Antoni Camins; Carlos Beas-Zárate
Journal:  J Mol Neurosci       Date:  2014-08-30       Impact factor: 3.444

4.  Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.

Authors:  Natalie Tomaszewski; Xulei He; Victoria Solomon; Mitchell Lee; Wendy J Mack; Joseph F Quinn; Meredith N Braskie; Hussein N Yassine
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Calcium-permeable AMPA receptors in neonatal hypoxic-ischemic encephalopathy (Review).

Authors:  Xiao-Juan Tang; Feng Xing
Journal:  Biomed Rep       Date:  2013-07-30

6.  Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells.

Authors:  Marzieh Zonouzi; Massimiliano Renzi; Mark Farrant; Stuart G Cull-Candy
Journal:  Nat Neurosci       Date:  2011-10-09       Impact factor: 24.884

Review 7.  Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease.

Authors:  Berenice A Gutierrez; Agenor Limon
Journal:  Biomedicines       Date:  2022-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.